Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

8.395 +0.765 (+10.03%)
Streaming Delayed Price Updated: 2:09 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
31 32 Next >
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From June 14, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44 
Via Benzinga
News headline image
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From June 10, 2022 ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67 
Via Benzinga
News headline image
Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13 
Via Benzinga
News headline image
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78 
Via Benzinga
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72 
Via Benzinga
Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and are still... 
Via FinancialNewsMedia
News headline image
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From June 3, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75 
Via Benzinga
News headline image
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry ↗
In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its... 
Via Benzinga
News headline image
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 31, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36 
Via Benzinga
News headline image
Psychedelic Compounds-Based Stocks Continue To Decline ↗
Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From May 26, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34 
Via Benzinga
News headline image
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45 
Via Benzinga
News headline image
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company ↗
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 24, 2022 ↗
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61 
Via Benzinga
News headline image
Cybin, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68 
Via Benzinga
News headline image
Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology ↗
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
News headline image
Can Psilocybin Help With Treatment-Resistant Depression? COMPASS Pathways Study Shows Promising Results ↗
COMPASS Pathways plc (NASDAQ: CMPS), a mental health care company, presented positive data from the randomized, controlled, double-blind study of psilocybin therapy, at the American Psychiatric... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 20, 2022 ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77 
Via Benzinga
News headline image
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say ↗
Patents are the golden eggs of the booming psychedelic space. 
Via Benzinga
News headline image
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29 
Via Benzinga
News headline image
Cybin, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55 
Via Benzinga
News headline image
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32 
Via Benzinga
News headline image
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 16, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
News headline image
Psychedelic Compounds-Based Stocks Index Imploding ↗
Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high. 
Via Talk Markets
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.